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Primary  congenital  glaucoma  (PCG)  is 
characterized by an anatomical defect in the 
trabecular meshwork (trabeculodysgenesis) and 
onset in the neonatal or infantile period, generally 
before the age of 3 years. The developmental 
anomaly in the anterior chamber angle manifests 
by increased intraocular pressure, corneal edema, 
excessive tearing, photophobia, enlargement of the 
globe (buphthalmos) and corneal opacification. 
It is the most severe form of glaucoma, having 
both sporadic and familial patterns with an 
incidence of 1:10,000 to 1:2,500 of live births. In 
familial cases, the pattern of inheritance is usually 
autosomal recessive. 
So far, three PCG loci have been identified 
by linkage analysis in multiple affected families: 
GLC3A, GLC3B, and GLC3C. The gene associated 
with GLC3A, cytochrome P450 1B1 (CYP1B1), is 
a member of the cytochrome P450 superfamily 
of genes and was the first gene linked to PCG 
in 1998. Its mutations are responsible for the 
disease in 20-100% of patients from different 
ethnicities. The rate of CYP1B1 mutations in 
Iranian PCG subjects has been reported to 
be 70%. Although physiological studies have 
confirmed that mutations in CYP1B1 can cause the 
disease, the pathway by which it affects normal 
development of the anterior chamber remains 
unknown. Additionally, mutations in myocilin 
(MYOC), a gene generally associated with early 
onset (juvenile) primary open angle glaucoma, 
have occasionally been reported in PCG.
In late 2009, the second gene for PCG was 
reported by two research groups, one of which 
was Iranian. Narooie-Nejad and colleagues 
recently performed autozygosity mapping in 
three Iranian PCG families and encountered two 
novel mutations in a gene overlapping with the 
GLC3C locus on chromosome 14q24.2-14q24.3. 
They reported two disease-segregating loss of 
function mutations in LTBP2, namely p.Ser472fsX3 
and p.Tyr1793fsX55. The latter mutation causes 
a defect close to the C-terminal of the encoded 
protein. Ali et al independently reported null 
mutations in LTBP2 in PCG patients. The gene 
itself encodes latent transforming growth factor 
beta binding protein 2 (LTBP2) which is expressed 
in human eyes within the trabecular meshwork 
and ciliary processes. Abnormal expression of 
LTBP2 is thought to be relevant to the etiology 
of PCG. 
LTBP2 contains 36 exons and encodes a 
matrix protein containing 1,821 amino acids. This 
protein is a member of a superfamily composed 
of fibrillins and LTBP proteins. These proteins 
contain tandem arrays of epidermal growth 
factor-like motifs, interspersed with characteristic 
transforming growth factor beta (TGF-β) binding 
protein-like motifs. TGF-βs constitute a family of 
potent multifunctional cytokines that modulate 
many cellular and physiologic processes. They exist 
extracellularly as latent complexes awaiting to be 
activated by appropriate signals. Although the 
precise function of LTBP2 remains unknown, there 
is evidence for this protein to have roles in tissue 
repair processes and cell adhesion. Mutations 
in the related gene can affect the structure and 
function of its protein and interfere with binding 
to fibrillin 1 and fibulin 5, leading to changes in 
the elastic properties of the ciliary processes and 
the trabecular meshwork. These alterations may 
directly or indirectly affect aqueous fluid outflow 
contributing to the PCG phenotype. 
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